AU718458B2 - Novel DNA and process for preparing protein using the DNA - Google Patents

Novel DNA and process for preparing protein using the DNA Download PDF

Info

Publication number
AU718458B2
AU718458B2 AU38661/97A AU3866197A AU718458B2 AU 718458 B2 AU718458 B2 AU 718458B2 AU 38661/97 A AU38661/97 A AU 38661/97A AU 3866197 A AU3866197 A AU 3866197A AU 718458 B2 AU718458 B2 AU 718458B2
Authority
AU
Australia
Prior art keywords
dna
sequence
ocif
leu
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU38661/97A
Other languages
English (en)
Other versions
AU3866197A (en
Inventor
Tomonori Morinaga
Nobuaki Nakagawa
Hisataka Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of AU3866197A publication Critical patent/AU3866197A/en
Application granted granted Critical
Publication of AU718458B2 publication Critical patent/AU718458B2/en
Assigned to SANKYO COMPANY LIMITED reassignment SANKYO COMPANY LIMITED Alteration of Name(s) in Register under S187 Assignors: SNOW BRAND MILK PRODUCTS CO., LTD.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU38661/97A 1996-08-19 1997-08-19 Novel DNA and process for preparing protein using the DNA Ceased AU718458B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8235928A JPH1057071A (ja) 1996-08-19 1996-08-19 新規ｄｎａ及びそれを用いた蛋白質の製造方法
JP8-235928 1996-08-19
PCT/JP1997/002859 WO1998007840A1 (fr) 1996-08-19 1997-08-19 Nouveaux adn et procede de production de proteines a l'aide de ces derniers

Publications (2)

Publication Number Publication Date
AU3866197A AU3866197A (en) 1998-05-11
AU718458B2 true AU718458B2 (en) 2000-04-13

Family

ID=16993321

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38661/97A Ceased AU718458B2 (en) 1996-08-19 1997-08-19 Novel DNA and process for preparing protein using the DNA

Country Status (12)

Country Link
EP (1) EP0874045A1 (OSRAM)
JP (1) JPH1057071A (OSRAM)
KR (1) KR20000064276A (OSRAM)
CN (1) CN1198776A (OSRAM)
AU (1) AU718458B2 (OSRAM)
CA (1) CA2235148A1 (OSRAM)
FI (1) FI980853L (OSRAM)
HU (1) HUP0001837A3 (OSRAM)
NO (1) NO981748L (OSRAM)
NZ (1) NZ330400A (OSRAM)
WO (1) WO1998007840A1 (OSRAM)
ZA (1) ZA977402B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005964A1 (en) * 1999-07-19 2001-01-25 St. Vincent's Institute Of Medical Research Inhibitor of osteoclast precursor formation

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919434B1 (en) 1995-02-20 2005-07-19 Sankyo Co., Ltd. Monoclonal antibodies that bind OCIF
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
CA2274987C (en) 1996-12-23 2012-01-24 Immunex Corporation Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
DE69834699T3 (de) 1997-04-15 2013-11-14 Daiichi Sankyo Co., Ltd. Neues protein und verfahren zu dessen herstellung
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
ES2284203T5 (es) 1997-04-16 2016-03-11 Amgen Inc. Proteínas de unión a osteoprotegerina y sus receptores
DE69834719D1 (de) 1997-09-24 2006-07-06 Sankyo Co Methode zur diagnose von abnormalem knochenstoffwechsel
DE69939822D1 (de) 1998-05-14 2008-12-11 Immunex Corp Verfahren zur hemmung der wirkung der osteoklasten
TW529954B (en) 1998-10-28 2003-05-01 Sankyo Co Agent for treating abnormal bone metabolism
AU7720600A (en) * 1999-09-27 2001-04-30 Eli Lilly And Company Osteoprotegerin regulatory region
AU2002253133B2 (en) 2001-04-03 2008-02-28 Societe Des Produits Nestle S.A. Osteoprotegerin in milk
CA2446723C (en) 2001-05-25 2014-01-21 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to trail receptors
CA2481074A1 (en) 2002-04-05 2003-10-23 Amgen Inc. Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005964A1 (en) * 1999-07-19 2001-01-25 St. Vincent's Institute Of Medical Research Inhibitor of osteoclast precursor formation

Also Published As

Publication number Publication date
CN1198776A (zh) 1998-11-11
EP0874045A4 (OSRAM) 1998-11-18
WO1998007840A1 (fr) 1998-02-26
ZA977402B (en) 1999-02-18
FI980853A0 (fi) 1998-04-17
CA2235148A1 (en) 1998-02-26
MX9803086A (es) 1998-11-29
FI980853A7 (fi) 1998-06-15
FI980853L (fi) 1998-06-15
NO981748L (no) 1998-06-18
AU3866197A (en) 1998-05-11
JPH1057071A (ja) 1998-03-03
NZ330400A (en) 1999-05-28
EP0874045A1 (en) 1998-10-28
NO981748D0 (no) 1998-04-17
KR20000064276A (ko) 2000-11-06
HUP0001837A3 (en) 2002-09-30
HUP0001837A2 (hu) 2000-09-28

Similar Documents

Publication Publication Date Title
AU654316B2 (en) Osteogenic factor
AU718458B2 (en) Novel DNA and process for preparing protein using the DNA
US6569434B1 (en) Vascular endothelial cell growth factor C subunit
TW538049B (en) A novel human osteoclastogenesis inhibitory factor and a process for preparing the same
AU650893B2 (en) O-glycosylated alpha-2 interferon
EP0309050A1 (en) Human insulin-like growth factor analogs with reduced binding to serum carrier proteins and their production in yeast
US20030092175A1 (en) Human proteins having transmembrane domains and dnas encoding these proteins
NZ287447A (en) Synthetic peptide analogs of human lung surfactant protein sp-c
JPH05306297A (ja) 新規なハイブリド形質転換成長因子
KR100880371B1 (ko) Ｃｎｓ 장애의 치료를 위한 ｔｇｆ－ｒ 시그널화 억제제
EP0624645B1 (en) Human chondromodulin-I protein
JP2001524083A (ja) テイコプラニン誘導体
WO1998038302A2 (en) TETRODOTOXIN-SENSITIVE SODIUM CHANNEL α-SUBUNIT
WO1999055863A1 (fr) Nouveau polypeptide, adnc le codant et son utilisation
MXPA98003086A (en) Novel dnas and process for producing proteins by using the same
CA2098283A1 (en) Oxidation resistant variants of parathyroid hormone
CA2324424A1 (en) Method for searching steroid sulfatase inhibitors
EP0806477B1 (en) Use of a recombinant dna comprising dna coding for smooth muscle-type myosin heavy-chain sm1 isoform protein in the manufacture of a medicament
JP3527760B2 (ja) 新規骨形成誘導蛋白質、それをコードするｄｎａ及び該蛋白質の製造方法並びにそれを有効成分とする骨形成誘導剤
EP1192181B1 (en) Modulation of angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor for the treatment of tumor
JP2000514654A (ja) 下垂体分化因子およびその使用方法
JPH05308990A (ja) 新規糖タンパク質、ポリペプチド並びにその製造方法及 び遺伝子
JPWO2000001405A1 (ja) 軟骨細胞の分化促進剤
WO1997037019A1 (fr) Inhibiteur de proliferation cellulaire

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: SANKYO CO., LTD.

Free format text: FORMER OWNER WAS: SNOW BRAND MILK PRODUCTS CO., LTD.